Search   
MSDS  
:
 Indol-5-ol, 3-(2-aminoethyl)-
CAS  
:
 50-67-9
SYNONYMS  
:
 * 3-(beta-Aminoethyl)-5-hydroxyindole
* 3-(2-Aminoethyl)indol-5-ol
* Antemoqua
* Antemovis
* Ds substance
* Enteramine
* Hippophain
* 5-HT
* 5-Hta
* 5-Hydroxy-3-(beta-aminoethyl)indole
* 5-Hydroxytryptamine
* Serotonin
* Serotonine
* Substance DS
* Substanz DS
* Thrombocytin
* Thrombotonin
* Tryptamine, 5-hydroxy-

                     *** CHEMICAL IDENTIFICATION ***

RTECS NUMBER            : NM2450000
CHEMICAL NAME           : Indol-5-ol, 3-(2-aminoethyl)-
CAS REGISTRY NUMBER     : 50-67-9
BEILSTEIN REFERENCE NO. : 0143524
REFERENCE               : 5-22-12-00016 (Beilstein Handbook Reference)
LAST UPDATED            : 199709
DATA ITEMS CITED        : 27
MOLECULAR FORMULA       : C10-H12-N2-O
MOLECULAR WEIGHT        : 176.24
WISWESSER LINE NOTATION : T56 BMJ D2Z GQ
COMPOUND DESCRIPTOR     : Drug
                          Reproductive Effector
SYNONYMS/TRADE NAMES :
   * 3-(beta-Aminoethyl)-5-hydroxyindole
   * 3-(2-Aminoethyl)indol-5-ol
   * Antemoqua
   * Antemovis
   * Ds substance
   * Enteramine
   * Hippophain
   * 5-HT
   * 5-Hta
   * 5-Hydroxy-3-(beta-aminoethyl)indole
   * 5-Hydroxytryptamine
   * Serotonin
   * Serotonine
   * Substance DS
   * Substanz DS
   * Thrombocytin
   * Thrombotonin
   * Tryptamine, 5-hydroxy-
 
                       *** HEALTH HAZARD DATA ***
 
                        ** ACUTE TOXICITY DATA **
 
TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 285 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   PSCBAY Psychopharmacology Service Center, Bulletin.  (Bethesda, MD)  V.1-3,
   1961-65.  For publisher information, see PSYBB9.  Volume(issue)/page/year:
   2,17,1963
 
TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intravenous
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 30 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   PSCBAY Psychopharmacology Service Center, Bulletin.  (Bethesda, MD)  V.1-3,
   1961-65.  For publisher information, see PSYBB9.  Volume(issue)/page/year:
   2,17,1963
 
TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 60 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   MZUZA8 Meditsinskii Zhurnal Uzbekistana.  (V/O Mezhdunarodnaya Kniga, 113095
   Moscow, USSR) No.1-    1957-  Volume(issue)/page/year: (3),61,1985
 
TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 160 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   IJPPAZ Indian Journal of Physiology and Pharmacology.  (All India Institute
   of Medical Sciences, Dept. of Physiology, Ansari Nagar, New Delhi 110 029,
   India)  V.1-    1957-  Volume(issue)/page/year: 17,31,1973
 
TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 601 mg/kg
TOXIC EFFECTS :
   Behavioral - somnolence (general depressed activity)
   Behavioral - ataxia
   Gastrointestinal - hypermotility, diarrhea
REFERENCE :
   FATOAO Farmakologiya i Toksikologiya (Moscow).  For English translation, see
   PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2-   
   1939-  Volume(issue)/page/year: 26,10,1963
 
TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intravenous
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 81 mg/kg
TOXIC EFFECTS :
   Behavioral - tremor
   Behavioral - convulsions or effect on seizure threshold
REFERENCE :
   FATOAO Farmakologiya i Toksikologiya (Moscow).  For English translation, see
   PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2-   
   1939-  Volume(issue)/page/year: 26,10,1963
 
TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intramuscular
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 750 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans
   Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium)  V.4-   
   1898-  Volume(issue)/page/year: 112,319,1957
 
TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Unreported
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 250 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   85GDA2 "CRC Handbook of Antibiotic Compounds," Vols.1- ,  Berdy, J., Boca
   Raton, FL, CRC Press, 1980-  Volume(issue)/page/year: 8(1),122,1982
 
TYPE OF TEST            : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE       : Intravenous
SPECIES OBSERVED        : Mammal - cat
DOSE/DURATION           : 5 mg/kg
TOXIC EFFECTS :
   Cardiac - other changes
   Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
   FATOAO Farmakologiya i Toksikologiya (Moscow).  For English translation, see
   PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2-   
   1939-  Volume(issue)/page/year: 26,10,1963
 
TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intravenous
SPECIES OBSERVED        : Rodent - guinea pig
DOSE/DURATION           : 12800 ug/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans
   Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium)  V.4-   
   1898-  Volume(issue)/page/year: 168,373,1967
 
                          ** REPRODUCTIVE DATA **
 
TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 10 mg/kg
SEX/DURATION            : female 12 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
   resorbed implants per total number of implants)
   Reproductive - Specific Developmental Abnormalities - other developmental
   abnormalities
REFERENCE :
   FKGCAR Fortschritte der Kiefer-und Gesichts-Chirurgie.  (Georg Thieme
   Verlag, Postfach 732, D-7000 Stuttgart 1, Fed. Rep. Ger.)  V.1-    1955-
   Volume(issue)/page/year: 21,226,1976
 
TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 10 mg/kg
SEX/DURATION            : female 18 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Effects on Embryo or Fetus - extra-embryonic structures
   (e.g., placenta, umbilical cord)
   Reproductive - Effects on Embryo or Fetus - fetal death
REFERENCE :
   ARPAAQ Archives of Pathology.  (Chicago, IL)  V.5(3)-50(3), 1928-50;
   V.70-99, 1960-75.  For publisher information, see APLMAS.
   Volume(issue)/page/year: 81,257,1966
 
TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 20 mg/kg
SEX/DURATION            : female 6 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured
   before birth)
REFERENCE :
   ANREAK Anatomical Record.  (Alan R. Liss, Inc., 41 E. 11th St., New York, NY
   10003)  V.1-    1906/08-  Volume(issue)/page/year: 196,71A,1980
 
TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 110 mg/kg
SEX/DURATION            : female 1-22 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Specific Developmental Abnormalities - Central Nervous System
   Reproductive - Specific Developmental Abnormalities - eye/ear
   Reproductive - Specific Developmental Abnormalities - body wall
REFERENCE :
   JOPDAB Journal of Pediatrics.  (C.V. Mosby Co., 11830 Westline Industrial
   Dr., St. Louis, MO 63141) V.1-    1932-  Volume(issue)/page/year:
   63,394,1963
 
TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 110 mg/kg
SEX/DURATION            : female 1-22 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
   resorbed implants per total number of implants)
   Reproductive - Effects on Newborn - live birth index (measured after birth)
REFERENCE :
   JOPDAB Journal of Pediatrics.  (C.V. Mosby Co., 11830 Westline Industrial
   Dr., St. Louis, MO 63141) V.1-    1932-  Volume(issue)/page/year:
   63,394,1963
 
TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 10 mg/kg
SEX/DURATION            : female 13 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
   resorbed implants per total number of implants)
   Reproductive - Effects on Embryo or Fetus - fetal death
REFERENCE :
   ARZNAD Arzneimittel-Forschung. Drug Research.  (Editio Cantor Verlag,
   Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.)  V.1-    1951-
   Volume(issue)/page/year: 25,626,1975
 
TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 100 mg/kg
SEX/DURATION            : male 5 day(s) pre-mating
TOXIC EFFECTS :
   Reproductive - Paternal Effects - testes, epididymis, sperm duct
   Reproductive - Paternal Effects - prostate, seminal vesicle, Cowper's gland,
   accessory glands
REFERENCE :
   ENDOAO Endocrinology (Baltimore).  (Williams & Wilkins Co., 428 E. Preston
   St., Baltimore, MD 21203) V.1-    1917-  Volume(issue)/page/year:
   71,827,1962
 
TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 240 mg/kg
SEX/DURATION            : female 1-6 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
   resorbed implants per total number of implants)
REFERENCE :
   JOENAK Journal of Endocrinology.  (Biochemical Soc. Book Depot, POB 32,
   Commerce Way, Colchester, Essex CO2 8HP, UK)  V.1-    1939-
   Volume(issue)/page/year: 26,85,1963
 
TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 320 mg/kg
SEX/DURATION            : female 14 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Fertility - abortion
REFERENCE :
   JOENAK Journal of Endocrinology.  (Biochemical Soc. Book Depot, POB 32,
   Commerce Way, Colchester, Essex CO2 8HP, UK)  V.1-    1939-
   Volume(issue)/page/year: 26,85,1963
 
TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 10 mg/kg
SEX/DURATION            : female 7-12 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
   resorbed implants per total number of implants)
   Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured
   before birth)
   Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
   e.g., stunted fetus)
REFERENCE :
   JPMSAE Journal of Pharmaceutical Sciences.  (American Pharmaceutical Assoc.,
   2215 Constitution Ave., NW, Washington, DC 20037)  V.50-    1961-
   Volume(issue)/page/year: 58,406,1969
 
TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 10 mg/kg
SEX/DURATION            : female 11 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Specific Developmental Abnormalities - urogenital system
REFERENCE :
   JPMSAE Journal of Pharmaceutical Sciences.  (American Pharmaceutical Assoc.,
   2215 Constitution Ave., NW, Washington, DC 20037)  V.50-    1961-
   Volume(issue)/page/year: 58,406,1969
 
TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 1 mg/kg
SEX/DURATION            : female 8 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Specific Developmental Abnormalities - body wall
   Reproductive - Specific Developmental Abnormalities - Central Nervous System
REFERENCE :
   JPMSAE Journal of Pharmaceutical Sciences.  (American Pharmaceutical Assoc.,
   2215 Constitution Ave., NW, Washington, DC 20037)  V.50-    1961-
   Volume(issue)/page/year: 58,406,1969
 
TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 240 mg/kg
SEX/DURATION            : female 11-16 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Effects on Embryo or Fetus - fetal death
REFERENCE :
   SCIEAS Science.  (American Assoc. for the Advancement of Science, 1333 H
   St., NW, Washington, DC 20005)  V.1-    1895-  Volume(issue)/page/year:
   131,1101,1960
 
TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Intravenous
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 10 mg/kg
SEX/DURATION            : female 7-12 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
   resorbed implants per total number of implants)
REFERENCE :
   JPMSAE Journal of Pharmaceutical Sciences.  (American Pharmaceutical Assoc.,
   2215 Constitution Ave., NW, Washington, DC 20037)  V.50-    1961-
   Volume(issue)/page/year: 58,406,1969

                              *** REVIEWS ***
 
   TOXICOLOGY REVIEW
   ARVPAX Annual Review of Pharmacology.  (Palo Alto, CA)  V.1-15, 1961-75. For
   publisher information, see ARPTDI.  Volume(issue)/page/year: 5,447,1965

   TOXICOLOGY REVIEW
   PRSMA4 Proceedings of the Royal Society of Medicine.  (New York, NY) V.1-70,
   1907-77.  For publisher information, see JRSMD9. Volume(issue)/page/year:
   62,317,1969

         *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA ***

NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA :
   NOES - National Occupational Exposure Survey (1983)
     NOES Hazard Code - X6095
       No. of Facilities: 7 (estimated)
       No. of Industries: 1
       No. of Occupations: 1
       No. of Employees: 202 (estimated)
       No. of Female Employees: 195 (estimated)

 
                            *** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
Indolo(1,7-ab)(1)benzazepine-1-ethanamine,6,7-dihydro-N-methyl-N-(phenylmethyl)-,monohydrochloride 57529-83-6
Indolo(1,7-ab)(1)benzazepine-1-ethanamine,6,7-dihydro-N,N,2-trimethyl- 57529-86-9
Indolo(1,7-ab)(1)benzazepine-1-methanamine,6,7-dihydro-N,N-dimethyl- 57529-89-2
Indolo(1,7-ab)(1)benzazepine-2-methanamine,6,7-dihydro-N,N-dimethyl-, monohydrochloride 41987-47-7
Indolo(1,7-ab)(1)benzazepine-2-methanamine,6,7-dihydro-N,N-dimethyl-1-phenyl- 57529-92-7
Indolo(1,7-ab)(1)benzazepine-2-methanamine,6,7-dihydro-N,N,1-trimethyl- 57529-91-6
2-Indolinone,3-(2-(tert-butylamino)ethyl)-1-(dimethylamino)-3-phenyl-, monohydrochloride 40713-82-4
7H-Indolo(3,4-gh)(1,4)benzoxazine,4,6,6a,8,9,10a-hexahydro-5-bromo-7-methyl-, oxalate,(+-)-(6-ars,10-ars)- 84132-04-7
7H-Indolo(3,4-gh)(1,4)benzoxazine,4,6,6a,8,9,10a-hexahydro-7-methyl-,monohydrochloride, (+-)-, (6-ars,10-ars)- 77291-63-5
7H-Indolo(3,4-gh)(1,4)benzoxazine,4,6,6a,8,9,10a-hexahydro-, monohydrochloride, (+-)-,(6-ars,10-ars) 80952-17-6
7H-Indolo(3,4-gh)(1,4)benzoxazine,4,6,6a,8,9,10a-hexahydro-7-propyl-,monohydrochloride, (+-)-, (6-ars,10-ars)- 80952-18-7
7H-Indolo(3,4-gh)(1,4)benzoxazine,4,5,5a,6,6a,8,9,10a-octahydro-7-propyl-, (+-)-,(5a-RS(5a-alpha,6a-beta,10a-alpha))- 84132-03-6
Indolo(7,6-g)indole-3,8-dimethanaminium,1,6-dihydro-N,N,N,N',N',N'-hexamethyl-, bis(methylsulfate) 84132-03-6
Indol-5-ol 1953-54-4
1H-Indol-5-ol,2-(4-(acetyloxy)phenyl)-1-ethyl-3-methyl-, acetate(ester) 86111-26-4
Indol-5-ol, 3-(2-aminoethyl)- 50-67-9
Indol-5-ol, 3-(2-aminoethyl)-, acetate (ester),adipate (1:1) 19628-29-6
2-Indolinone,1-((p-chlorobenzyl)methylamino)-3-(2-(diethylamino)ethyl)-3-phenyl- 33391-15-0
Indol-5-ol, 3-(2-aminoethyl)-, adipate 16031-83-7
Indol-5-ol, 3-(2-aminoethyl)-, p-aminobenzoate(ester), dihydrochloride 19616-00-3
Indol-5-ol, 3-(2-aminoethyl)-, benzoate (ester),monoacetate 18518-64-4
Indol-5-ol, 3-(2-aminoethyl)-,(m-chlorophenyl)carbamate, hydrochloride 73816-59-8
Indol-5-ol, 3-(2-aminoethyl)-, compd. with creatininesulfate 971-74-4
Indol-5-ol, 3-(2-aminoethyl)-, compd. with creatininesulfate monohydrate, mixed with sodium nitrite 971-74-4
Indol-5-ol, 3-(2-aminoethyl)-, diethylcarbamate,acetate 73816-60-1
Indol-5-ol, 3-(2-aminoethyl)-, maleate 18525-25-2
Indol-5-ol, 3-(2-aminoethyl)-, methylcarbamate,hydrochloride 73816-61-2
1H-Indol-5-ol, 3-(2-aminoethyl)-, monohydrochloride,nitrosated 73816-61-2
2-Indolinone,1-((o-chlorobenzyl)methylamino)-3-(3-(diethylamino)propyl)-3-phenyl- 33456-35-8
Indol-5-ol, 3-(2-aminoethyl)-, phenylcarbamate,hydrochloride 73816-62-3
Indol-5-ol, 3-(2-aminoethyl)-, propionate (ester),adipate (1:1) 19628-28-5
Indol-5-ol, 3-(2-aminoethyl)-, succinate 21716-89-2
Indol-5-ol, 3-(2-aminoethyl)-, sulfate 2906-14-1
1H-Indol-5-ol, 3-(2-(4-amino-1-piperidinyl)ethyl)-,hydrochloride, hydrate (2:4:1) 35633-80-8
Indol-5-ol, 3-(2-aminopropyl)-, hydrochloride 101651-82-5
Indol-6-ol, 3-(2-aminopropyl)-5-methoxy-,hydrochloride 101651-83-6
Indol-3-ol,2-(((p-(bis(2-chloroethyl)amino)phenyl)imino)methyl)- 101651-84-7
3-Indolol,5-bromo-2-(9-chloro-3-hydroxynaphtho(1,2-b)thien-2-yl)-, bis(hydrogen sulfate), disodium salt 101651-84-7
Indol-6-ol,4-chloro-2-(2,6-dichloro-4-hydroxyphenyl)-1-ethyl- 83364-03-8
2-Indolinone,1-((p-chlorobenzyl)methylamino)-3-(2-(dimethylamino)ethyl)-3-phenyl- 33391-14-9
Indol-6-ol,4-chloro-2-(2,6-dichloro-4-hydroxyphenyl)-1-methyl- 83364-02-7
Indol-5-ol, 3-(2,3-diaminopropyl)-, dihydrochloride 101651-85-8
Indol-5-ol, 3-(2-(dibutylamino)ethyl)-,monohydrochloride 101651-85-8
1H-Indol-4-ol,4-(2-(3,4-dimethoxyphenyl)ethenyl)octahydro-,(3a-alpha,4-beta,4(Z),7a- alpha)-(+-)-,(Z)-2-butenedioate (2:1) (salt) 66690-81-1
Indol-4-ol, 3-(2-(dimethylamino)ethyl)- 520-53-6
Indol-5-ol, 3-(2-(dimethylamino)ethyl)- 487-93-4
Indol-6-ol, 3-(2-(dimethylamino)ethyl)- 1476-33-1
1H-Indol-5-ol, 3-(2-(dimethylamino)ethyl)-, bioxalate 4382-50-7
Indol-4-ol, 3-(2-(dimethylamino)ethyl)-, dihydrogenphosphate 520-52-5
Indol-5-ol, 3-(2-(dimethylamino)ethyl)-, oxalate 2963-79-3

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com